SEB Asset Management’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.66M Hold
245,043
– – 0.03% 383
2026
Q2
$13.2M Hold
245,043
– – 0.05% 296
2026
Q1
$11.8M Buy
+245,043
New +$16.8M 0.05% 289

Other funds holding GPCR

SEB Asset Management's GPCR Position: Q3 2026 in Review

SEB Asset Management held its Structure Therapeutics (GPCR) position steady in Q3 2026 at 245,043 shares worth $7.66M. The position accounts for 0.03% of the portfolio, ranked #383.

SEB Asset Management first reported a position in GPCR in Q1 2026 and has held it in 3 quarters since. The position peaked at $13.2M in Q2 2026. 171 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

  • SEB Asset Management held 245,043 shares of Structure Therapeutics worth $7.66M as of Q3 2026.
  • SEB Asset Management left its Structure Therapeutics share count unchanged in Q3 2026.
  • Structure Therapeutics made up 0.03% of SEB Asset Management's portfolio in Q3 2026, its #383 holding.
  • SEB Asset Management first reported a position in Structure Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • SEB Asset Management's Structure Therapeutics position peaked at $13.2M in Q2 2026.
  • 171 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.